Kue Peng Lim

1.2k total citations
26 papers, 745 citations indexed

About

Kue Peng Lim is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kue Peng Lim has authored 26 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Immunology. Recurrent topics in Kue Peng Lim's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Head and Neck Cancer Studies (6 papers). Kue Peng Lim is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Head and Neck Cancer Studies (6 papers). Kue Peng Lim collaborates with scholars based in Malaysia, United Kingdom and United States. Kue Peng Lim's co-authors include Sok Ching Cheong, Annie Wai Yeeng Chai, Stephen S. Prime, Gayani Pitiyage, E. Ken Parkinson, Soo‐Hwang Teo, Yazan Hassona, Nicola Cirillo, Rosnah Binti Zain and Farida Fortune and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Kue Peng Lim

25 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kue Peng Lim Malaysia 14 382 282 183 176 78 26 745
John I. Song United States 16 494 1.3× 490 1.7× 147 0.8× 256 1.5× 206 2.6× 34 1.1k
Shilpi Arora United States 15 680 1.8× 260 0.9× 60 0.3× 262 1.5× 98 1.3× 31 948
Fumie Omotehara Japan 17 454 1.2× 253 0.9× 63 0.3× 197 1.1× 65 0.8× 32 769
Tim N. Beck United States 14 352 0.9× 298 1.1× 99 0.5× 151 0.9× 114 1.5× 28 756
Sandra Ortiz‐Cuaran France 16 486 1.3× 527 1.9× 151 0.8× 297 1.7× 208 2.7× 35 1.0k
Mariko Mihara Japan 21 745 2.0× 674 2.4× 42 0.2× 230 1.3× 203 2.6× 38 1.3k
Ivan Vrhovec Slovenia 17 330 0.9× 302 1.1× 57 0.3× 523 3.0× 37 0.5× 34 871
Qing‐Mei He China 21 893 2.3× 287 1.0× 164 0.9× 648 3.7× 139 1.8× 44 1.3k
Xifa Zhou China 16 583 1.5× 190 0.7× 81 0.4× 354 2.0× 104 1.3× 34 817

Countries citing papers authored by Kue Peng Lim

Since Specialization
Citations

This map shows the geographic impact of Kue Peng Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kue Peng Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kue Peng Lim more than expected).

Fields of papers citing papers by Kue Peng Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kue Peng Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kue Peng Lim. The network helps show where Kue Peng Lim may publish in the future.

Co-authorship network of co-authors of Kue Peng Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Kue Peng Lim. A scholar is included among the top collaborators of Kue Peng Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kue Peng Lim. Kue Peng Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savelyeva, Natalia, et al.. (2025). Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5. Journal of Translational Medicine. 23(1). 1414–1414.
2.
3.
Nordin, Muhammad Luqman, Ahmad Khusairi Azemi, Abu Hassan Nordin, et al.. (2023). Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects. Pharmaceuticals. 16(7). 923–923. 5 indexed citations
4.
Lim, Kue Peng, et al.. (2023). The origins, roles and therapies of cancer associated fibroblast in liver cancer. Frontiers in Oncology. 13. 1151373–1151373. 10 indexed citations
5.
Lau, Shin Hin, Thomas George Kallarakkal, Rosnah Binti Zain, et al.. (2022). Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia. Frontiers in Immunology. 13. 954567–954567. 11 indexed citations
6.
Lim, Kue Peng, et al.. (2021). Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines. Frontiers in Molecular Biosciences. 8. 623475–623475. 6 indexed citations
7.
Chai, Annie Wai Yeeng, Kue Peng Lim, & Sok Ching Cheong. (2019). Translational genomics and recent advances in oral squamous cell carcinoma. Seminars in Cancer Biology. 61. 71–83. 196 indexed citations
8.
Rajadurai, Pathmanathan, Ching Ching Ng, Lee Fah Yap, et al.. (2019). An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma. Disease Markers. 2019. 1–10. 13 indexed citations
9.
Yap, Lee Fah, Sathibalan Ponniah, Soo‐Hwang Teo, et al.. (2015). Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma. PLoS ONE. 10(11). e0130464–e0130464. 14 indexed citations
10.
Lim, Kue Peng, Siti Mazlipah Ismail, Mannil Thomas Abraham, et al.. (2014). CD4+CD25hiCD127low Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients. PLoS ONE. 9(8). e103975–e103975. 51 indexed citations
11.
Lim, Kue Peng, Soo‐Hwang Teo, Zainal Ariff Abdul Rahman, et al.. (2014). Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy. Human Vaccines & Immunotherapeutics. 10(11). 3214–3223. 10 indexed citations
12.
Hassona, Yazan, Nicola Cirillo, Kue Peng Lim, et al.. (2013). Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β. Carcinogenesis. 34(6). 1286–1295. 80 indexed citations
13.
Pitiyage, Gayani, Kue Peng Lim, Muy‐Teck Teh, et al.. (2012). Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs ‐1 and ‐2) in fibroblasts are early indictors of oral sub‐mucous fibrosis and ageing. Journal of Oral Pathology and Medicine. 41(6). 454–462. 30 indexed citations
14.
Chong, Chan‐Eng, Kue Peng Lim, Christina A. Marsh, et al.. (2012). Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome. Cancer Letters. 321(1). 18–26. 22 indexed citations
15.
Chong, Chan‐Eng, Kue Peng Lim, Sheila Nathan, et al.. (2012). Novel MDM2 splice variants identified from oral squamous cell carcinoma. Oral Oncology. 48(11). 1128–1135. 9 indexed citations
16.
Pitiyage, Gayani, Predrag Slijepčević, Kue Peng Lim, et al.. (2010). Senescent mesenchymal cells accumulate in human fibrosis by a telomere‐independent mechanism and ameliorate fibrosis through matrix metalloproteinases. The Journal of Pathology. 223(5). 604–617. 78 indexed citations
17.
Lim, Kue Peng, Nicola Cirillo, Yazan Hassona, et al.. (2010). Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. The Journal of Pathology. 223(4). 459–469. 80 indexed citations
18.
Yang, Yi‐Hsin, Siti Mazlipah Ismail, Rosnah Binti Zain, et al.. (2008). MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset. Oral Oncology. 45(6). 496–500. 15 indexed citations
19.
Lim, Kue Peng, et al.. (2007). HPV infection and the alterations of the pRB pathway in oral carcinogenesis. Oncology Reports. 17(6). 1321–6. 14 indexed citations
20.
Lim, Kue Peng, et al.. (2005). Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event. Oncology Reports. 14(4). 963–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John I. Song Breakdown of academic impact, for papers by Shilpi Arora Breakdown of academic impact, for papers by Fumie Omotehara Breakdown of academic impact, for papers by Tim N. Beck Breakdown of academic impact, for papers by Sandra Ortiz‐Cuaran Breakdown of academic impact, for papers by Mariko Mihara Breakdown of academic impact, for papers by Ivan Vrhovec Breakdown of academic impact, for papers by Qing‐Mei He Breakdown of academic impact, for papers by Xifa Zhou
Rankless by CCL
2026